BioSpace News Archive

According to Vision Research Reports, the depth of anesthesia monitoring devices market size is expected to reach US$ 401 million by 2030 and expanding growth at a CAGR of 5.2% from 2021 to 2030.

The global heat therapy market reached valuation at US$ 1 Bn in 2020 and predicted to hit over US$ 1.65 billion by 2030, expand at a moderate CAGR of 4.1% from 2021 to 2030.

The global in vitro fertilization test market size is expected to hit around US$ 2.8 billion by 2030 and is expected to grow at a noteworthy CAGR of 6.1% from 2020 to 2030.

The global minimally invasive surgery market was valued at US$ 8.6 Bn in 2020 and is expected to reach US$ 23.4 by 2030.

The global smart exoskeleton market value reached at US$ 201 million in 2020 and predicted to surpass around US$ 3.4 billion by 2030, expanding at a noteworthy CAGR of 31% from 2021 to 2030.

Beating out San Francisco and Boston, new report shows New York City Metro Area has the Most Life Sciences Employment Opportunities in the Country.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), announces new data from 1st line NSCLC patients (Part A) of the Phase II TACTI-002 trial evaluating Immutep’s lead product candidate, eftilagimod alpha (“efti” or “IMP321”) in combination with MSD’s anti-PD-1 therapy KEYTRUDA® (pembrolizumab) in 114 patients.

The global ultrasound devices market value reached at US$ 6.1 Bn in 2020 and predicted to surpass around US$ 12.3 billion by 2030, expanding at a noteworthy CAGR of 6.1% from 2021 to 2030.

Sutro Biopharma, Inc. announced that on June 3, 2022, the Compensation Committee of Sutro’s Board of Directors granted 75,000 shares of Sutro Biopharma stock options and 80,000 Restricted Stock Units of Sutro common stock to three new employees.

Freeline Therapeutics Holdings plc disclosed the receipt of a notice on May 31, 2022 from the Nasdaq Stock Market LLC that the Company is not currently in compliance with the $1.00 minimum bid price requirement for continued listing of the Company’s American Depositary Shares on the Nasdaq Global Select Market, as set forth in Nasdaq Listing Rule 5450.